Drägerwerk AG & Co. KGaA (pref) Cash Flow Conversion Efficiency

Latest as of March 2026: 0.037x

Drägerwerk AG & Co. KGaA (pref) cash flow conversion efficiency. Based on the latest financial reports, Drägerwerk AG & Co. KGaA (pref) (DRW3) has a cash flow conversion efficiency ratio of 0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€62.00 Million ≈ $72.49 Million USD) by net assets (€1.66 Billion ≈ $1.94 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Drägerwerk AG & Co. KGaA (pref) (2013–2025)

Cash flow conversion efficiency of Drägerwerk AG & Co. KGaA (pref) from 2013 to 2025. This chart illustrates how Drägerwerk AG & Co. KGaA (pref)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Drägerwerk AG & Co. KGaA (pref) for real-time trading data and today's change.

Drägerwerk AG & Co. KGaA (pref) Cash Flow Conversion Ratio Explained

Drägerwerk AG & Co. KGaA (pref) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Drägerwerk AG & Co. KGaA (pref) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Drägerwerk AG & Co. KGaA (pref) ranked by their cash flow conversion efficiency. Also see DRW3 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Aptus Value Housing Finance India Limited NSE:APTUS	-0.025x
Guangzhou Hexin Instrument Co Ltd SHG:688622	N/A
Shinyoung HappyTomorrow No.5 Special Purpose Acquisition Company KQ:323280	-0.079x
Shanxi Sanwei Group Co Ltd SHE:000755	0.066x
Paradise Co. Ltd KQ:034230	0.028x
Sano Bruno's Enterprises Ltd TA:SANO1	0.033x
Business First Bancshares Inc NASDAQ:BFST	0.027x
Zoomlion Heavy Industry Science and Technology Co. Ltd F:8CZ	0.019x

Annual Cash Flow Conversion Efficiency for Drägerwerk AG & Co. KGaA (pref) (2013–2025)

The table below shows the annual cash flow conversion efficiency of Drägerwerk AG & Co. KGaA (pref) from 2013 to 2025. Review Drägerwerk AG & Co. KGaA (pref) (DRW3) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€1.63 Billion ≈ $1.90 Billion	€238.33 Million ≈ $278.63 Million	0.146x	+34.41%
2024-12-31	€1.54 Billion ≈ $1.80 Billion	€167.31 Million ≈ $195.60 Million	0.109x	-19.11%
2023-12-31	€1.41 Billion ≈ $1.65 Billion	€189.68 Million ≈ $221.75 Million	0.135x	+223.13%
2022-12-31	€1.32 Billion ≈ $1.54 Billion	€-144.23 Million ≈ $-168.62 Million	-0.109x	-135.80%
2021-12-31	€1.26 Billion ≈ $1.47 Billion	€384.89 Million ≈ $449.97 Million	0.305x	-31.37%
2020-12-31	€1.03 Billion ≈ $1.21 Billion	€459.98 Million ≈ $537.76 Million	0.445x	+191.27%
2019-12-31	€1.08 Billion ≈ $1.26 Billion	€164.42 Million ≈ $192.22 Million	0.153x	+3936.11%
2018-12-31	€1.08 Billion ≈ $1.26 Billion	€4.09 Million ≈ $4.78 Million	0.004x	-97.18%
2017-12-31	€1.07 Billion ≈ $1.25 Billion	€143.34 Million ≈ $167.57 Million	0.134x	-31.07%
2016-12-31	€1.00 Billion ≈ $1.17 Billion	€195.32 Million ≈ $228.35 Million	0.195x	+361.89%
2015-12-31	€945.93 Million ≈ $1.11 Billion	€39.86 Million ≈ $46.60 Million	0.042x	-79.90%
2014-12-31	€896.61 Million ≈ $1.05 Billion	€187.98 Million ≈ $219.77 Million	0.210x	+150.33%
2013-12-31	€815.97 Million ≈ $953.95 Million	€68.34 Million ≈ $79.90 Million	0.084x	--

About Drägerwerk AG & Co. KGaA (pref)

F:DRW3 Germany Medical Devices

Market Cap

$1.04 Billion

€885.80 Million EUR

Market Cap Rank

#8388 Global

#1123 in Germany

Share Price

€103.00

Change (1 day)

-1.53%

52-Week Range

€66.80 - €125.60

All Time High

€125.60